06–08 December | Klinikum rechts der Isar | Munich | Germany
Programme 20182018-09-21T13:51:07+00:00

Preliminary Programme 2018

Download Programme

Thursday, December 6

* Competing for the MAC Award

09.00-10.35

CAR 1: Clinical and imaging variables in asymptomatic carotid patients with an increased stroke risk - critical revision of the ESVS/ESC GL 2017

Barbara RantnerClinical variables with an increased late stroke risk
David SpenceSpontaneous embolisation on TCD and carotid plaque features
Peter RinglebSilent infarction and impaired cerebrovascular reactivity
Kosmas ParaskevasGrade of carotid stenosis and stenosis progression
Jonathan Nadjiri MRI features of unstable carotid plaques
Jens GöttlerMulti-modal MRI identifies carotid patients with reduced cerebral blood flow and oxidative metabolism
Alison Halliday Keynote Lecture: How to select asymptomatic carotid patients for CEA (or CAS) BMT plus - a critical review of the ESVS/ESC guidelines

11.00-12.45

CAR 2: More news on carotid revascularization stratgies and long-term outcomes in (a)symptomatic carotid patients

Ralf KolvenbachTranscarotid stenting with flow reversal:  does the kind of stent matter?
Klaus MatthiasEarly and one year data from the Scaffold (micromesh) CAS Trial
Sumaira MacDonaldControl of the microembolic burden of the carotid bifurcation lesion: comparison of various endovascular strategies
Christos LiapisTotal occlusion of the internal carotid artery - not a benign condition
Kosmas ParaskevasOutcomes following eversion vs. conventional CEA in RCTs and observational studies - a systematic review
Armelle Meershoek*Long term outcomes of symptomatic patients undergoing hybrid revascularization for extracranial carotid artery tandem stenosis
Marc SchermerhornKeynote lecture: Transcarotid stenting (T-CAR) versus CEA and transfemoral CAS in the SVS Vascular Quality Initiative (VQI, USA)
Hans FörstlSpecial Lecture 1: Cognitive impairment and dementia in politicians

13.30-15.00

CAR 3: Prospective meta-analyses of individual patient data from investigator-initiated RCTs (SPACE, CREST, ACST, ICSS, EVA3-S, GALA)

Tilman ReiffStroke and TIA rates at one year in SPACE-2: BMT versus CEA versus CAS in asymptomatic carotid stenosis
Richard BulbuliaCurrent status and perspectives of ACST-2, CREST-2, and ECST-2
Gert de BorstSafety of carotid revascularization in patients with a history of coronary heart disease
Christof KnappichPerioperative and clinical variables affecting the 30-day risk of stroke or death after symptomatic CEA
Dylan MorrisRisk factors for major operative complications following asymptomatic CEA - 4.440 CEA from VACS, ACAS, ACST-1 and the GALA trial
Evelien de Vries*Carotid stent failure as a predictor for periprocedural stroke or death after CAS - a substudy from ICSS
Leo BonatiKeynote Lecture: Immediate, intermediate, and long-term results after CEA and CAS in four RCTs on symptomatic carotid stenosis

15.00-16.00

CAR 4: Short communications on Carotid Diseases

Klaus MatthiasCarotid artery aneurysms - what endovascular treatment can achieve
Vanessa PourierGadolinium enhancement and white matter lesions in extracranial carotid artery aneurysms
Astrid HovingThe performance of ultrasound particle image velocimetry in a carotid artery phantom with stent
Christoph SchäfferNon-invasive assessment of carotid plaque burden with tomographic ultrasound
Armelle MeershoekTreatment of internal carotid artery NEar occlusiON (NEON study): An individual patient data meta-analysis
Ihor KobzaThe choice of the optimal method of surgical correction of atherosclerotic carotid lesions
Peter KonstantiniukThe ASA classification predicts the ipsilateral stroke free survival in asymptomatic octogenarians with elective CEA
Evelien de VriesStandardization of semiautomatic tortuosity measurements in the carotid artery
Leonie FassaertDefining the awake blood pressure in patients undergoing CEA
Pedro Pinto SousaModerate (50-69%) symptomatic carotis stenosis - what should we do?

* Competing for the MAC Award

09.00-10.30

AOR 1: Short communications on Aortic Diseases

Ahmed EleshraDifferent zones (0-2) of hybrid de-branching endovascular aortic repair: outcomes and stroke analysis
Mikhail ChernyavskiyMid-term results of hybrid aortic arch repair
Pedro Pinto SousaAcute aortic syndrome - three typical case presentations
Arnaud KerzmannResults of left subclavian artery revascularization prior to elective TEVAR
Ahmad NagaCombined TEVAR and EVAR to treat thoracic type IB endoleak and infrarenal AAA
Rita AugustoLate Type 1a endoleak after EVAS: a unique challenge
Sigitas UrbonaviciusUrine biomarkers for AAA rupture - is it possible?
Albert BuschAngiogenese-inhibition and AAA
Liu ShengliangRole of neutrophil extracellular traps in AAA disease development and progression
Jasamin Coles-BlackAn easily reproducable 3D printed AAA model using open source digital tools
Pedro Pinto SousaEndovascular aneurysm repair in octogenarians
Jacinta CamposMycotic aortic aneurysm secondary to intravesical BCG instillation - is an endovascular approach an effective solution?
Makhmud AkhmadEndovascular diagnostics and treatment of acute abdominal bleedings after hepato-pancreatico-duodenal surgery
Matthias TrennerImpact of the patient risk on the volume-outcome effect for AAA surgery
Stefan OckertShort Report: endovascular one stop shopping: EVAR + TAVI
Lars LönnComputer-controlled aortic occlusion (REBOA) for the treatment of cardiac arrest and bleedings

11.00-12.35

AOR 2: Dismantling AAAs - novel insights into disease mechanisms and future therapies

Andrew BakerExploiting novel targets in vascular remodeling and disease formation
Anders WanhainenUpdate on non-invasive treatments for AAA disease
Rebecka HultgrenGender aspects in AAA disease
Joy RoyBiomechanical modeling of AAA growth and rupture; a clinical perspective
Wolf Eilenberg*The association of neutrophil activation markers with morphological features of AAA
Markus Wagenhäuser*Nicotine is a regulator of segmental aortic stiffening - Implications for AAA development
Valentina Paloschi*Aorta-on-a-chip: a novel tool to gain molecular insights into aneurym disease

13.30-14.45

AOR 3: Biomechanics and simulation of aortic aneurysms

T. Christian GasserPredicting three-dimensional AAA growth from CT-A images
Stephane AvrilPatient-specific numerical simulation of endovascular aneurysm repair
Michael GeeIn Silico EVAR for Abdominal Aortic Aneurysms
Tina CohnertAdvances in biomechanic and structural AAA wall analysis
Benedikt ReutersbergThe SCAN study reveals, that cardiovascular patients should always be screened for AAA

* Competing for the MAC Award

15.30-17.00

PAD 1: Innovative imaging and below-the-knee treatment modalities

Jean-Paul de VriesDETECT-PAD II: computerized and patient specific model to determine pressure gradients in borderline stenosis with MRA / CTA.
Jos van den BergZero contrast procedure by use of unenhanced MRA and CO2 angiography
Michael Rasper3D non-contrast-enhanced ECG-gated MR angiography of the lower extremities
Jean-Paul de VriesThe REPEAT study: validation of perfusion angiography measurements for below-the-knee arteries in CLI patients
Marianne BrodmannEarly results from a RCT on below-the-knee drug-eluting balloons
Peter GoverdeOne year results of real-life use of the latest generation of balloon expandable DES in below-the-knee treatment
Achim Neufang Surgical arterialisation of the plantar venous system for foot salvage after failed endovascular or operative revascularisation

17.20-18.35

PAD 2: Peripheral and mesenteric vascular emergencies

Anders WanhainenOpen or endovascular revascularization in the treatment of acute lower limb ischaemia
Kerstin Stoklasa Outcomes of a consecutive series of 708 patients with acute limb ischaemia
Heli Järve*Acute mesenteric ischaemia: irreversible versus reversible bowel damage - a single centre experience
Suzanne Evans*Mesenteric vascular injuries in trauma: a National Trauma Data Bank (NTDB) study from the US
Adel Kamhawy Arterial injury associated with pediatric supracondylar humerus fracture - exploration or observation?
Ralf KolvenbachKeynote Lecture: Civilian and pediatric vascular trauma management - an overview

17.30-18.40

SPECIAL SESSION 1: Hot topics in radiation protection 2018

Tina CohnertAdvanced radiation protection in the Hybrid OR with Zero Gravity
Stefan OckertRadiation exposure during C-arm supported EVAR with the Siemens Pheno system
Bijan ModaraiRisks associated with protracted low dose radiation exposure
Dittmar BöcklerEvidence of radiation induced cataracts and brain tumors
Stefan OckertEVAS might be associated with a decrease in intraoperative radiation dose as compared to EVAR

Friday, December 7

* Competing for the MAC Award

08.30-10.00

CAR 5: Carotid artery disease - from genes to therapies

Martin DichgansStroke Genetics: discovery, biology, and clinical implications
Jan NilssonFactors associated with progression of carotid disease in high risk patients
Thorsten KesslerImplementing genetics into clinical practice in cardiovascular disease management
Judith SluimerInterplay of oxygen sensors, inflammation and cholesterol metabolism in atherosclerosis
Hanna Winter*Long non-coding RNA NUDT6 regulates fibrous cap thickness in advanced atherosclerosis
Joachim Schmidt*Expression of human somatostatin receptors and glucose transporters in carotid artery stenosis and aneurysms

10.30-11.30

CAR 6: Carotid ultrasound session on carotid plaque burden and plaque vulnerability

David SpenceKeynote Lecture: Carotid plaque burden predicts future cardiovascular events - why and how I do it!
Steven RogersWill carotid plaque volume assessed by 3D tomographic ultrasound be an altenative indicator for CEA or CAS?
Holger PoppertHow to detect and to stratify DUS findings at the carotid bifurcation (echolucency, ulceration, etc.)
Marjolijn Rots*Correlation between plaque characteristics and presence of preoperative white matter lesions in patients undergoing CEA
Igor KoncarTAXINOMISIS - a multidisciplinary EU project on stratification of patients with carotid artery disease

* Competing for the MAC Award

10.30-12.10

AOR 4: Ascending aorta and aortic arch

Jes S LindholtDANCAVAS trial: the incidence of coexisting aortic aneurysms and why ascending AA might be overdiagnosed!
Martin Czerny The EACTS/ESVS expert consensus document for the treatment of thoracic aortic pathologies affecting the aortic arch
Ralf KolvenbachStatus of ascending aortic stent grafts in true aneurysms
Martin CzernyTotal endovascular treatment of aortic arch pathologies using branched endografts
Ali ShahriariRepair of acute DeBakey I dissections using a novel dissection- specific arch hybrid graft (AMDS)
Celia RigaContact force assessment in the arch during TEVAR: How do different graft designs perform?
Jonathan NadjiriAssessment of flow-displacement und wall-shear-stress by 4-D aortic MR-Angiography - new options as compared to CTA
Julian ScottSPECIAL LECTURE 2: Sarcopenia and outcomes in Vascular Surgery

13.00-14.40

AOR 5: Thoracic/Thoraco-abdominal aneurysm and dissections

Dittmar BöcklerPrevalence of the computed tomographic morphological DISSECT predictors in uncomplicated Stanford Type B aortic dissection
Igor KoncarEarly TEVAR in acute type B dissection
Bijan ModaraiContemporary treatment of type B aortic dissection: Is there a need for a disease specific approach to endografting?
Eric VerhoevenTreatment of chronic aortic dissections with fenestrated and branched endografts
Celia RigaFrozen elephant trunk techniques for chronic Type B dissections
Athanasios KatsargyrisInner branches as an additional option besides fenestrations and branches in TAAA branched grafting
Colin BicknellPrevention and revision of TEVAR utilising EndoAnchors to reduce and treat endoleak
Sebastian DebusThe SPIDERgraft: can this novel technique decrease complications after thoracoabdominal repair?
Christos LiapisSide effects of EVAR and EVAR on the heart - myth or reality?

15.05-16.40

AOR 6: A critical revision of the new AAA guidelines from the ESVS, SVS and the German Vascular Society (DGG), and NICE (UK)I

Anders Wanhainen Keynote Lecture: The new AAA guidelines from the ESVS – what is new and what is different from the 2017 SVS AAA guidelines?
Sebastian DebusAre there any different recommendations in the 2018 AAA guidelines from the German Vascular Society (DGG)?
Mike WyattChanges to the management of patients with AAA in the UK: Is NICE out of touch with worldwide best practice?
Athanasios GiannoukasSome small AAAs (4.5-5.5 cm) should be treated - How to select them?
Thomas Schmitz-RixenHow valid is the diameter threshold of 5/5,5 cm for repair and do we need new RCTs to further improve our AAA management?
Jes S LindholtDo we need another RCT for AAA 5-5.5 or 5.5-6.0 cm?
Clark ZeebregtsAccuracy of routine endoscopy diagnosing colonic ischaemia after abdominal aortic aneurysm repair: a meta-analysis.
Igor KoncarMorphological predictors of an increased AAA rupture risk
Rachael ForsytheMulti-modality molecular and cellular imaging to predict AAA disease progression: towards personalised assessment of disease

17.00-18.30

AOR 7: Complex AAA and endoleak management

Christian ReepsRole of aortic surgery in radical cancer resection
Lars LönnQualitative review of studies reporting on re-interventions after elective EVAR - a systematic review
Marc SchermerhornSelected Type I and III EL at completion of FEVAR are safe to observe
Colin BicknellEndovascular strategies for treatment of type I EL in EVAR
Albert BuschExpansion and atrophy - aortic wall development after EVAR with endoleak type II
Jean-Paul de VriesDeterminants of successful and unsuccessful deployment of EndoAnchors in hostile necks; evaluation of >300 implants
Matthias TrennerIntraarterial CEUS - first experience with a new technique to detect early endoleaks in EVAR
Clark ZeebregtsThe GLOBAL FACT Registry: a world-wide registry with core lab analysis of fenestrated Anaconda for complex aortic aneurysms
Alexander OberhuberThe (JOTEC®) iliAc BRAnch device for exclusion of Hypogastric Artery aneurysMs - ABRAHAM trial

* Competing for the MAC Award

08:30-10:10

PAD 3: Challenges in PAD: long and calcified femoro-popliteal lesions, in-stent-restenosis (ISR), and wound healing

Peter GoverdeNew DAWN - one year results combining Supera VMI and DCB for the  treatment of long femoro-popliteal lesions
Jean-Paul de Vries2 years results of the RAPID trial - RCT comparing Legflow DCB with Supera stenting vs. Supera alone for SFA lesions
Thomas ZellerAre there any differences between different drug-eluting stents for femoro-popliteal lesions
Alexander Zimmermann The SVS objective performance goals (OPG) are achievable for surgical therapy in a consecutive CLI all-comers cohort
Gunnar Tepe2 years results of the COPA CABANA RCT of DCB versus PTA for femoro-popliteal in-stent-restenosis
Jos van den BergCurrent status of in-stent-restenosis treatment in the SFA
Peter GoverdeFlow dynamics and patency rates indicate superiority of covered over kissing aortic bifurcation stents
Alexander Gombert* Closed-incision negative-pressure therapy reduces vascular surgical site infections: a prospective RCT (AIMS trial)
George GeroulakosTime of complete healing of leg ulcers following revascularization for critical limb ischaemia

14.30-15.35

PAD 4: Update on lipid-lowering therapy in peripheral atherosclerosis

David SpenceBest medical treatment for asymptomatic carotid disease - optimal LDL levels are achievable!
Richard Bulbulia Intensive lipid-lowering for plaque stabilisation and regression? Implications for surgeons and our patients!
Barbara RantnerCardiovascular morbidity and mortality in patients with intermittent claudication - medical long-term intervention is a MUST
Mark SchermerhornSurvival after lower extremity revascularization for critical limb-threatening ischaemia (CLTI) is better with high-dose statin
NNPCSK9 inhibitor evolocumab in patients with and without PAD

15.35-16.30

PAD 5: Update on periprocedural and long-term platelet inhibition and anticoagulation in PAD

Christine Espinola-KleinUpdate on periprocedural and long-term antithrombotic management in PAD
Michael SpannaglHow to assess and individualize platelet inhibition in PAD
Thomas StadlbauerPlatelet inhibition PLUS low-dose anticoagulation - a new paradigm for all PAD patients?
NNPAD and atrial fibrillation - how to balance out anticoagulation and antithrombotic treatment

17.00-18.00

PAD 6: Short communications on Peripheral Arterial Disease (PAD)

Dmitry DombrovskyiTransplantation of stem cells of different origin for the treatment of lower limb ischaemia
Chiara MozziniCardiovascular diseases: focus on endoplasmatic reticulum stressand NRF2 signalling
Akshitha KesharajuSarcopenia as predictor of mortality and morbidity following major lower limb amputation
Mohamed NagibTransbrachial approach as an alternative method in the management of aortoilliac occlusive arterial diseases.
Sabine Dallmann-SieberAcute occlusions of the infrarenal aorta - single-center experience of 68 patients in a 14-year-period
Bianca Marinelli TeixeiraRare atherosclerotic aneurysms of the dorsalis pedis artery in young women - case reports and literature review
Sohiel Nagib Cost effectiveness of Carbon Dioxide as Contrast Medium for the Endovascular treatment of PAOD in patients with renal dysfunction
Yuriy LevchakAdventitial cystic disease of the lower extremities main vessels
Emad HusseinInfragenicular PAOD in south mediterranean patients - towards a sound endovascular strategy

12.00-13.00

VEN 1: Venous Challenge - successful strategies to treat venous lesions (Industry-Sponsored)

Tobias SteinkeThe endovascular option for AV-fistula creation
Tobias SteinkeHow to treat the AV-Fistula stenosis best
Houman JalaieThe right way to treat chronic venous lesions - Tips and tricks in diagnostic, indication, and treatment
Nils KucherWhat we learned from the „Attract“-Study

12.30-14.00

SPECIAL SESSION 2: Team training

Markus KleemannAugmented reality for navigated EVAR
Mark KaschwichA modular approach for an endovascular training environment using rapid prototyping as part of the Nav-EVAR project
Lars LönnMetric-based virtual reality simulation - a paradigm shift in training for severe stroke
Celia RigaAn optimised team training for EVAR & TEVAR - how do you set it up and what is the evidence?
Dittmar BöcklerHow to train the surgical staff in the hybrid OR in radiation protection
Heiko WendorffMid-term effects of an Intensive radiation-protection-Training on the Intraoperative radiation exposure in the Hybrid OR

Saturday, December 8

09.00-09.55

VEN 2: Short communications on Venous Diseases

Luís GamasVenous stenting: initial experience and follow up in a Portuguese center
Mohamed NagibLaser crossectomy versus anterior accessory saphenous vein laser ablation in treating the anterior accessory saphenous vein reflux
Sohiel NagibAcute upper extremity deep vein thrombosis (DVT) - indications and effectiveness of superior caval filters
Mohamed IsmailRole of Inferior vena cava filter insertion prior to thrombolysis of acute ilio femoral deep venous thrombosis
Mangesh TarteInferior caval obstruction - limited role of endovenous therapy
Andrij NykonenkoDiagnostic management of the „nutcracker syndrome“
Larysa ChernukhaManagement of the pelvic congestion synsdrome
Olena KashyrovaModern approaches in the treatment of diffuse forms of extremity congenital vascular malformations with the presence of microfistulas
Mangesh TarteCombined role of Laser ablation, Ethanol embolisation, and foam sclerotherapy in the treatment of venous malformations
Adel KamhawySurgical management of high and low-flow vascular malformations

09.55-11.00

VEN 3: Deep vein thrombosis (DVT) - conservative and recanalizing strategies

Armando MansilhaTreating acute DVT with DOACs - advances and challenges
Andrij NykonenkoSurgical versus conservative treatment of deep venous thrombosis: follow-up and quality of life
Stefan OckertQuality of life and post-thrombotic syndrome after surgical thrombectomy of acute iliofemoral DVT
George GeroulakosComplications of endovascular treatment for the management of May-Thurner syndrome
Alun Davies (tbc)Antithrombotic therapy following venous stenting: International Delphi Consensus

11.30-13.00

VEN 4: New developments in lower leg varicosis

Sigitas UrbonaviciusA novel view at the pathogenesis of varicose veins: proteomic analysis
Thomas HirschInterventional treatment of perforator veins
Jan Beyer-WestendorfThromboembolic complications in superficial-vein thrombosis under Rivaroxaban or Fondaparinux: the randomised SURPRISE trial
NNHigh ligation and crossectomy are still an option in superficial-vein thrombosis close to the sapheno-femoral junction
Alun Davies (tbc)Keynote Lecture: EVRA - a randomized trial of early endovenous ablation in venous ulceration
Thomas PröbstleCurrent status of non-termal/non-tumescent saphenous ablation
Thomas HirschWhat do we know about the allergenic risk of adhesive vein treatments?

13.30-15.00

VEN 5: Current guidelines on chronic venous diseases - a critical overview

Armando MansilhaKeynote lecture: why the current international guidelines are not always accurate to define the best technique for varicose veins
Alun Davies (tbc)Strengths and weakpoints of the 2017 ESVS guideline on chronic venous diseases
Mike WyattMultimodal treatment of small saphenous vein reflux
NNMultimodal treatment of greater saphenous vein reflux
NNPeriprocedural and long-term compression therapy - indications, evidence, and outcomes
Houman JalaieThe postthrombotic syndrome - prevention and recanalizing treatment strategies